Catalyst Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US14888U1016

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Patrick J Mcenany. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Patrick J Mcenany har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CPRX / Catalyst Pharmaceuticals, Inc. Director 4.281.702
US:KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Director 122.750
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Patrick J Mcenany. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CPRX / Catalyst Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CPRX / Catalyst Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-09-30 CPRX MCENANY PATRICK J 15.000 2,9700 15.000 2,9700 44.550 268 6.05 46.200 103,70
2019-10-03 CPRX MCENANY PATRICK J 10.000 4,8900 10.000 4,8900 48.900
2019-06-11 CPRX MCENANY PATRICK J 25.000 3,2300 25.000 3,2300 80.750
2018-12-19 CPRX MCENANY PATRICK J 20.000 2,2400 20.000 2,2400 44.800
2018-04-03 CPRX MCENANY PATRICK J 20.000 2,2900 20.000 2,2900 45.800
2017-09-05 CPRX MCENANY PATRICK J 20.000 2,5780 20.000 2,5780 51.560
2016-06-14 CPRX MCENANY PATRICK J 105.300 0,6508 105.300 0,6508 68.529
2016-04-26 CPRX MCENANY PATRICK J 50.000 0,6486 50.000 0,6486 32.430
2015-12-28 CPRX MCENANY PATRICK J 25.000 2,3890 25.000 2,3890 59.725
2015-10-01 CPRX MCENANY PATRICK J 10.000 2,8100 10.000 2,8100 28.100
2015-04-27 CPRX MCENANY PATRICK J 5.000 3,7900 5.000 3,7900 18.950
2015-01-08 CPRX MCENANY PATRICK J 50.000 2,7950 50.000 2,7950 139.750
2014-05-21 CPRX MCENANY PATRICK J 25.000 1,8890 25.000 1,8890 47.225
2014-02-07 CPRX MCENANY PATRICK J 25.000 1,8200 25.000 1,8200 45.500
2013-10-21 CPRX MCENANY PATRICK J 50.000 1,5946 50.000 1,5946 79.730
2013-02-19 CPRX MCENANY PATRICK J 50.000 0,4600 50.000 0,4600 23.000
2012-12-17 CPRX MCENANY PATRICK J 100.000 0,4450 100.000 0,4450 44.500
2012-11-15 CPRX MCENANY PATRICK J 100.000 0,4201 100.000 0,4201 42.010
2012-07-03 CPRX MCENANY PATRICK J 700 0,5350 700 0,5350 374
2012-07-02 CPRX MCENANY PATRICK J 30.500 0,5383 30.500 0,5383 16.418
2012-05-30 CPRX MCENANY PATRICK J 10.000 0,5790 10.000 0,5790 5.790
2012-05-24 CPRX MCENANY PATRICK J 31.250 0,8000 31.250 0,8000 25.000
2012-02-14 CPRX MCENANY PATRICK J 1.600 1,1000 1.600 1,1000 1.760
2012-02-14 CPRX MCENANY PATRICK J 23.400 1,1500 23.400 1,1500 26.910

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
Insidersalg CPRX / Catalyst Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CPRX / Catalyst Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-06-09 CPRX MCENANY PATRICK J 171.748 26,1100 171.748 26,1100 4.484.340 59 19.6350 -1.112.068 -24,80
2025-06-06 CPRX MCENANY PATRICK J 28.252 25,9450 28.252 25,9450 732.998
2024-11-20 CPRX MCENANY PATRICK J 72.500 21,2900 72.500 21,2900 1.543.525
2024-11-19 CPRX MCENANY PATRICK J 98.345 21,1880 98.345 21,1880 2.083.734
2024-11-14 CPRX MCENANY PATRICK J 44.655 21,7520 44.655 21,7520 971.336
2024-11-13 CPRX MCENANY PATRICK J 92.500 22,9780 92.500 22,9780 2.125.465
2024-11-12 CPRX MCENANY PATRICK J 70.000 23,4210 70.000 23,4210 1.639.470
2024-11-12 CPRX MCENANY PATRICK J 192.000 23,2010 192.000 23,2010 4.454.592
2024-11-11 CPRX MCENANY PATRICK J 230.000 23,5480 230.000 23,5480 5.416.040
2023-05-15 CPRX MCENANY PATRICK J 26.151 13,2300 26.151 13,2300 345.978
2022-11-21 CPRX MCENANY PATRICK J 150.000 15,3320 150.000 15,3320 2.299.800
2022-11-18 CPRX MCENANY PATRICK J 350.000 15,6220 350.000 15,6220 5.467.700
2022-09-14 CPRX MCENANY PATRICK J 946.846 15,4140 946.846 15,4140 14.594.684
2022-09-13 CPRX MCENANY PATRICK J 80.765 15,3290 80.765 15,3290 1.238.047
2022-08-19 CPRX MCENANY PATRICK J 125.000 14,0994 125.000 14,0994 1.762.425
2022-08-18 CPRX MCENANY PATRICK J 25.000 13,9340 25.000 13,9340 348.350
2022-08-18 CPRX MCENANY PATRICK J 50.000 13,9300 50.000 13,9300 696.500
2022-08-18 CPRX MCENANY PATRICK J 50.000 13,9590 50.000 13,9590 697.950
2022-08-18 CPRX MCENANY PATRICK J 50.000 13,9510 50.000 13,9510 697.550
2021-08-23 CPRX MCENANY PATRICK J 82.617 5,6250 82.617 5,6250 464.721
2021-08-20 CPRX MCENANY PATRICK J 54.161 5,5180 54.161 5,5180 298.860
2021-08-13 CPRX MCENANY PATRICK J 31.186 6,1740 31.186 6,1740 192.542
2021-08-13 CPRX MCENANY PATRICK J 31.529 6,0745 31.529 6,0745 191.523

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
Insiderkøb KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CPRX / Catalyst Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Insidersalg KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CPRX / Catalyst Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Patrick J Mcenany som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-10 2025-06-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
S - Sale -171.748 4.281.702 -3,86 26,11 -4.484.340 111.795.239
2025-06-10 2025-06-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
S - Sale -28.252 4.453.450 -0,63 25,94 -732.998 115.544.760
2024-12-11 2024-12-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 3.533 4.481.702 0,08
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -72.500 4.478.169 -1,59 21,29 -1.543.525 95.340.218
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 72.500 4.550.669 1,62 3,54 256.650 16.109.368
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -98.345 4.478.169 -2,15 21,19 -2.083.734 94.883.445
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 98.345 4.576.514 2,20 3,54 348.141 16.200.860
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -44.655 4.478.169 -0,99 21,75 -971.336 97.409.132
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 44.655 4.522.824 1,00 3,54 158.079 16.010.797
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -92.500 4.478.169 -2,02 22,98 -2.125.465 102.899.367
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 92.500 4.570.669 2,07 3,54 327.450 16.180.168
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -192.000 4.478.169 -4,11 23,20 -4.454.592 103.897.999
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 192.000 4.670.169 4,29 3,54 679.680 16.532.398
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -70.000 4.478.169 -1,54 23,42 -1.639.470 104.883.196
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 70.000 4.548.169 1,56 4,01 280.700 18.238.158
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -230.000 4.478.169 -4,89 23,55 -5.416.040 105.451.924
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 230.000 4.708.169 5,14 4,01 922.300 18.879.758
2024-08-26 2024-08-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
G - Gift -5.100 4.478.169 -0,11
2024-08-19 2024-08-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
G - Gift -45.000 4.483.269 -0,99
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 116.667 4.528.256 2,64
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 26.333 4.411.589 0,60
2024-01-03 2024-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 250.000 4.385.256 6,05 1,13 282.500 4.955.339
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -10.362 4.135.256 -0,25
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 26.333 4.145.618 0,64
2023-05-17 2023-05-16 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 173.849 4.119.285 4,41 0,79 137.341 3.254.235
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -26.151 3.945.436 -0,66 13,23 -345.978 52.198.118
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26.151 3.971.587 0,66 0,79 20.659 3.137.554
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -14.204 3.945.436 -0,36
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 58.333 3.959.640 1,50
2022-12-30 2022-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -10.000 3.901.307 -0,26
2022-12-30 2022-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
G - Gift -10.000 3.911.307 -0,26
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -12.133 3.921.307 -0,31
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30.834 3.933.440 0,79
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -150.000 3.902.606 -3,70 15,33 -2.299.800 59.834.755
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 150.000 4.052.606 3,84 2,24 336.000 9.077.837
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -350.000 3.902.606 -8,23 15,62 -5.467.700 60.966.511
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 350.000 4.252.606 8,97 2,24 784.000 9.525.837
2022-09-15 2022-09-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -946.846 3.902.606 -19,52 15,41 -14.594.684 60.154.769
2022-09-15 2022-09-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -80.765 4.849.452 -1,64 15,33 -1.238.047 74.337.250
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -125.000 4.930.217 -2,47 14,10 -1.762.425 69.513.102
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 125.000 5.055.217 2,54 2,53 316.250 12.789.699
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50.000 4.930.217 -1,00 13,95 -697.550 68.781.457
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 50.000 4.980.217 1,01 2,53 126.500 12.599.949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock,. par value $0.001 per share
M - Exercise 50.000 4.980.217 1,01 2,53 126.500 12.599.949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50.000 4.930.217 -1,00 13,96 -697.950 68.820.899
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 50.000 4.980.217 1,01 2,53 126.500 12.599.949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -50.000 4.930.217 -1,00 13,93 -696.500 68.677.923
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -25.000 4.930.217 -0,50 13,93 -348.350 68.697.644
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 25.000 4.955.217 0,51 2,53 63.250 12.536.699
2022-02-16 2022-02-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 175.000 3.665.834 5,01
2021-12-30 2021-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 270.000 3.490.834 8,38
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30.833 3.220.834 -0,95
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -12.132 4.930.227 -0,25
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30.833 4.942.359 0,63
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -120.000 3.251.667 -3,56
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -82.617 4.911.526 -1,65 5,62 -464.721 27.627.334
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 120.000 4.994.143 2,46 3,12 374.400 15.581.726
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -80.000 3.371.667 -2,32
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -54.161 4.874.143 -1,10 5,52 -298.860 26.895.521
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 80.000 4.928.304 1,65 3,12 249.600 15.376.308
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -100.000 3.451.667 -2,82
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -31.529 4.848.304 -0,65 6,07 -191.523 29.451.023
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
S - Sale -31.186 4.879.833 -0,64 6,17 -192.542 30.128.089
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 100.000 4.911.019 2,08 3,12 312.000 15.322.379
2021-01-04 2020-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 400.000 3.551.667 12,69
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30.833 3.151.667 -0,97
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
F - Taxes -7.507 4.811.019 -0,16
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
M - Exercise 30.833 4.818.526 0,64
2020-09-30 2020-09-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 15.000 4.787.693 0,31 2,97 44.550 14.219.448
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 92.500 3.182.500 2,99
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 740.000 3.090.000 31,49
2019-10-03 2019-10-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 10.000 4.772.693 0,21 4,89 48.900 23.338.469
2019-06-11 2019-06-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 25.000 4.762.693 0,53 3,23 80.750 15.383.498
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.667 2.350.000 7,63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.667 2.350.000 7,63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.666 2.016.666 9,01
2018-12-19 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20.000 4.737.693 0,42 2,24 44.800 10.612.432
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.667 1.850.000 9,90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.667 1.850.000 9,90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 166.666 1.516.666 12,35
2018-04-03 2018-04-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20.000 4.717.693 0,43 2,29 45.800 10.803.517
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 1.350.000 8,00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 1.350.000 8,00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 1.250.000 8,70
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26.667 0 -100,00
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26.667 4.697.693 0,57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -200.000 500.000 -28,57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 200.000 4.671.026 4,47 0,47 94.000 2.195.382
2017-09-05 2017-09-05 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 20.000 4.471.026 0,45 2,58 51.560 11.526.305
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Warrants to Purchase Common Stock
X - Other -31.250 0 -100,00 0,80 -25.000
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 31.250 4.451.026 0,71 1,04 32.500 4.629.067
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83.334 1.250.000 7,14
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83.333 1.166.666 7,69
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 83.333 1.166.666 7,69
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26.667 26.667 -50,00
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26.667 4.419.776 0,61
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 1.100.000 10,00
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 1.100.000 10,00
2016-06-14 2016-06-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 105.300 4.393.109 2,46 0,65 68.529 2.859.035
2016-04-26 2016-04-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 50.000 4.287.809 1,18 0,65 32.430 2.781.073
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 900.000 12,50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 900.000 12,50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
A - Award 100.000 800.000 14,29
2015-12-28 2015-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 25.000 4.237.809 0,59 2,39 59.725 10.124.126
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -26.666 53.334 -33,33
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 26.666 4.212.809 0,64
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock
M - Exercise -75.000 600.000 -11,11
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
F - Taxes -26.119 4.186.143 -0,62
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
M - Exercise 75.000 4.212.262 1,81 1,09 81.750 4.591.366
2015-10-01 2015-10-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
P - Purchase 10.000 4.137.262 0,24 2,81 28.100 11.625.706
2015-04-27 2015-04-27 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
P - Purchase 5.000 4.127.262 0,12 3,79 18.950 15.642.323
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
M - Exercise -364.804 786.250 -31,69
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
F - Taxes -67.539 4.122.262 -1,61
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
M - Exercise 364.804 4.189.801 9,54 0,68 249.891 2.870.014
2015-01-08 2015-01-08 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
P - Purchase 50.000 3.970.918 1,28 2,80 139.750 11.098.716
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26.667 1.151.054 2,37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26.667 1.151.054 2,37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units
A - Award 26.666 1.097.720 2,49
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100.000 1.221.054 8,92
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100.000 1.121.054 9,79
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 100.000 1.021.054 10,86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
M - Exercise -150.000 1.231.054 -10,86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share
M - Exercise 150.000 3.920.918 3,98 0,90 135.000 3.528.826
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153.334 1.381.054 12,49
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153.333 1.227.720 14,27
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 153.333 1.227.720 14,27
2014-07-02 2014-07-01 4 KOOL CESCA THERAPEUTICS INC.
Option
A - Award 25.000 122.750 25,58
2014-05-21 2014-05-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 25.000 3.656.247 0,69 1,89 47.225 6.906.651
2014-02-07 2014-02-07 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 25.000 3.631.247 0,69 1,82 45.500 6.608.870
2013-10-21 2013-10-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 50.000 3.606.247 1,41 1,59 79.730 5.750.521
2013-07-02 2013-07-01 4 KOOL THERMOGENESIS CORP
Option
A - Award 15.000 109.000 15,96
2013-02-20 2013-02-19 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 50.000 3.556.247 1,43 0,46 23.000 1.635.874
2012-12-18 2012-12-17 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 100.000 3.449.997 2,99 0,44 44.500 1.535.249
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66.667 936.054 7,67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66.667 936.054 7,67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock
A - Award 66.666 802.720 9,06
2012-11-15 2012-11-15 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 100.000 3.349.997 3,08 0,42 42.010 1.407.334
2012-07-05 2012-07-02 4 KOOL THERMOGENESIS CORP
Option
A - Award 15.000 100.500 17,54
2012-07-03 2012-07-03 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 700 3.249.997 0,02 0,54 374 1.738.748
2012-07-03 2012-07-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 30.500 3.249.297 0,95 0,54 16.418 1.749.097
2012-05-31 2012-05-30 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 10.000 3.218.797 0,31 0,58 5.790 1.863.683
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Warrants to Purchase Common Stock
P - Purchase 31.250 1.009.191 3,20
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 31.250 3.208.797 0,98 0,80 25.000 2.567.038
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 23.400 3.202.547 0,74 1,15 26.910 3.682.929
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share
P - Purchase 1.600 3.179.147 0,05 1,10 1.760 3.497.062
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)